Bioartificial Adrenal Device
April 28, 2015 | Terry Sharrer
Beta-O2 Technologies Ltd is an Israeli company which has developed an implantable device containing islet of Langerhans cells for treating type 1 diabetes. Now it is developing a similar device that can deliver living adrenal cells for controlling adrenocortical insufficiency—and, rely on xeno-transplants from pigs to humans. MORE
Image Credit: Beta-O2 Technologies Ltd and FierceMedicalDevices.com